Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
Die neuen Corona-Impfstoffe: Wie sie wirken, was zu beachten ist | BR24
Evaluation of COVID-19 vaccination strategies with a delayed second dose | medRxiv
Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination | Nature Communications
Changing the UK COVID-19 vaccine dosing schedule - POST
Real world' study shows Pfizer and Moderna vaccines were 90% effective
CDC changes Covid vaccine guidance to OK mixing Pfizer and Moderna shots
Pfizer Fact Sheet for Healthcare Providers for 5-11 years of age, orange cap (must dilute) 12082022
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet
What is the evidence for extending the SARS-CoV-2 (COVID-19) vaccine dosing schedule? | British Columbia Medical Journal
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England | Nature Communications
Evaluation of COVID-19 vaccination strategies with a delayed second dose | PLOS Biology
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection | NEJM
Who Didn't Get a Second Shingrix Shot? Implications for Multidose COVID-19 Vaccines | KFF
WHO recommends two doses of Pfizer COVID-19 vaccine within 21-28 days | Reuters
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | NEJM
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine - ScienceDirect
Pfizer's Vaccine Offers Strong Protection After First Dose - The New York Times
Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system - eClinicalMedicine
